BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15528376)

  • 21. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5.
    Isobe S; Tsimikas S; Zhou J; Fujimoto S; Sarai M; Branks MJ; Fujimoto A; Hofstra L; Reutelingsperger CP; Murohara T; Virmani R; Kolodgie FD; Narula N; Petrov A; Narula J
    J Nucl Med; 2006 Sep; 47(9):1497-505. PubMed ID: 16954559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
    Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of macrophage ApoE on atherosclerosis in LDL-receptor deficient mice.
    Tennert C; Teupser D; Mueller MA; Wilfert W; Renner-Müller I; Stein O; Stein Y; Sippel AE; Wolf E; Thiery J
    Biochem Biophys Res Commun; 2007 Sep; 361(3):574-9. PubMed ID: 17669363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
    Marais AD
    Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
    Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
    Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
    Mehta NU; Grijalva V; Hama S; Wagner A; Navab M; Fogelman AM; Reddy ST
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1152-63. PubMed ID: 27079878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis.
    Norsworthy PJ; Fossati-Jimack L; Cortes-Hernandez J; Taylor PR; Bygrave AE; Thompson RD; Nourshargh S; Walport MJ; Botto M
    J Immunol; 2004 Mar; 172(6):3406-14. PubMed ID: 15004139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins.
    Igbavboa U; Avdulov NA; Chochina SV; Wood WG
    J Neurochem; 1997 Oct; 69(4):1661-7. PubMed ID: 9326295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 9-cis β-Carotene Increased Cholesterol Efflux to HDL in Macrophages.
    Bechor S; Zolberg Relevy N; Harari A; Almog T; Kamari Y; Ben-Amotz A; Harats D; Shaish A
    Nutrients; 2016 Jul; 8(7):. PubMed ID: 27447665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.
    Zhao Z; de Beer MC; Cai L; Asmis R; de Beer FC; de Villiers WJ; van der Westhuyzen DR
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):168-73. PubMed ID: 15514202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E suppresses the type I inflammatory response in vivo.
    Ali K; Middleton M; Puré E; Rader DJ
    Circ Res; 2005 Oct; 97(9):922-7. PubMed ID: 16179587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Danhong injection inhibits the development of atherosclerosis in both Apoe⁻/⁻ and Ldlr⁻/⁻ mice.
    Chen Y; Liu M; Zhao T; Zhao B; Jia L; Zhu Y; Zhang B; Gao X; Li G; Li X; Xiang R; Han J; Duan Y
    J Cardiovasc Pharmacol; 2014 May; 63(5):441-52. PubMed ID: 24803317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein E mediates enhanced plasma high-density lipoprotein cholesterol clearance by low-dose streptococcal serum opacity factor via hepatic low-density lipoprotein receptors in vivo.
    Rosales C; Tang D; Gillard BK; Courtney HS; Pownall HJ
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1834-41. PubMed ID: 21597008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
    Bai L; Li Z; Li Q; Guan H; Zhao S; Liu R; Wang R; Zhang J; Jia Y; Fan J; Wang N; Reddy JK; Shyy JY; Liu E
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice.
    Du F; Gesang Q; Cao J; Qian M; Ma L; Wu D; Yu H
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
    Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
    PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G2A deficiency in mice promotes macrophage activation and atherosclerosis.
    Bolick DT; Skaflen MD; Johnson LE; Kwon SC; Howatt D; Daugherty A; Ravichandran KS; Hedrick CC
    Circ Res; 2009 Feb; 104(3):318-27. PubMed ID: 19106413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.